CBOE insider grant: 1,066 RSUs vesting through 2028
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cboe Global Markets (CBOE) reported an insider equity grant. A company officer (EVP, Global Head of Derivatives) received 1,066 restricted stock units (RSUs) on 10/20/2025. Each RSU represents a contingent right to receive one share of Cboe common stock.
The RSUs vest in three equal annual installments on February 19, 2026, February 19, 2027, and February 19, 2028. The filing lists direct ownership of 1,066 RSUs at a price of $0 per unit, reflecting a standard equity compensation award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hocking Robert A
Role
EVP, Global Head of Derivs.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 1,066 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 1,066 shares (Direct)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock. The restricted stock units vest in three equal annual installments on February 19, 2026, February 19, 2027, and February 19, 2028.
FAQ
What did Cboe Global Markets (CBOE) disclose in this Form 4?
A company officer received 1,066 RSUs on 10/20/2025, each representing a right to one share of common stock.
What is the vesting schedule for the CBOE RSUs?
The 1,066 RSUs vest in three equal annual installments on Feb 19, 2026, Feb 19, 2027, and Feb 19, 2028.
What role does the reporting person hold at CBOE?
The reporting person is listed as an Officer, titled EVP, Global Head of Derivs.
How many derivative securities are beneficially owned after the transaction?
The filing shows 1,066 RSUs beneficially owned on a direct (D) basis.
What does each RSU represent for CBOE?
Each restricted stock unit represents a contingent right to receive one share of Cboe common stock.
Was there a cash price for the RSUs reported by CBOE?
The RSUs are listed at a price of $0, consistent with equity compensation grants.